Co-Diagnostics CODX Stock
Co-Diagnostics Price Chart
Co-Diagnostics CODX Financial and Trading Overview
| Co-Diagnostics stock price | 1.2 USD |
| Previous Close | 1.04 USD |
| Open | 1.04 USD |
| Bid | 0 USD x 3200 |
| Ask | 0 USD x 2900 |
| Day's Range | 1.04 - 1.08 USD |
| 52 Week Range | 0.98 - 7.13 USD |
| Volume | 52.98K USD |
| Avg. Volume | 144.33K USD |
| Market Cap | 32.68M USD |
| Beta (5Y Monthly) | -0.645422 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.5 USD |
CODX Valuation Measures
| Enterprise Value | -41659868 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1739131 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.6964982 |
| Price/Book (mrq) | 0.29900333 |
| Enterprise Value/Revenue | -3.437 |
| Enterprise Value/EBITDA | 1.388 |
Trading Information
Co-Diagnostics Stock Price History
| Beta (5Y Monthly) | -0.645422 |
| 52-Week Change | -79.029% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.13 USD |
| 52 Week Low | 0.98 USD |
| 50-Day Moving Average | 1.3 USD |
| 200-Day Moving Average | 2.52 USD |
CODX Share Statistics
| Avg. Volume (3 month) | 144.33K USD |
| Avg. Daily Volume (10-Days) | 78.29K USD |
| Shares Outstanding | 30.26M |
| Float | 29.73M |
| Short Ratio | 6.1 |
| % Held by Insiders | 1.07% |
| % Held by Institutions | 19.42% |
| Shares Short | 598.77K |
| Short % of Float | 2.00% |
| Short % of Shares Outstanding | 1.98% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -261.59% |
| Operating Margin (ttm) | -258.77% |
| Gross Margin | 77.71% |
| EBITDA Margin | -247.62% |
Management Effectiveness
| Return on Assets (ttm) | -13.60% |
| Return on Equity (ttm) | -24.54% |
Income Statement
| Revenue (ttm) | 12.12M USD |
| Revenue Per Share (ttm) | 0.4 USD |
| Quarterly Revenue Growth (yoy) | -97.29% |
| Gross Profit (ttm) | 28.74M USD |
| EBITDA | -30014636 USD |
| Net Income Avi to Common (ttm) | -31708236 USD |
| Diluted EPS (ttm) | -1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 75.28M USD |
| Total Cash Per Share (mrq) | 2.49 USD |
| Total Debt (mrq) | 935.43K USD |
| Total Debt/Equity (mrq) | 0.85 USD |
| Current Ratio (mrq) | 23.801 |
| Book Value Per Share (mrq) | 3.612 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6736536 USD |
| Levered Free Cash Flow (ttm) | -3256899 USD |
Profile of Co-Diagnostics
| Country | United States |
| State | UT |
| City | Salt Lake City |
| Address | 2401 South Foothill Drive |
| ZIP | 84109 |
| Phone | 801 438 1036 |
| Website | https://www.codiagnostics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 145 |
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Q&A For Co-Diagnostics Stock
What is a current CODX stock price?
Co-Diagnostics CODX stock price today per share is 1.2 USD.
How to purchase Co-Diagnostics stock?
You can buy CODX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Co-Diagnostics?
The stock symbol or ticker of Co-Diagnostics is CODX.
Which industry does the Co-Diagnostics company belong to?
The Co-Diagnostics industry is Medical Devices.
How many shares does Co-Diagnostics have in circulation?
The max supply of Co-Diagnostics shares is 31.26M.
What is Co-Diagnostics Price to Earnings Ratio (PE Ratio)?
Co-Diagnostics PE Ratio is now.
What was Co-Diagnostics earnings per share over the trailing 12 months (TTM)?
Co-Diagnostics EPS is -1.2 USD over the trailing 12 months.
Which sector does the Co-Diagnostics company belong to?
The Co-Diagnostics sector is Healthcare.
Co-Diagnostics CODX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}